Laxmi Organic Industries Limited — Q4 FY25 earnings call

Call held 27 May 2025

Management summary

Laxmi Organic reported a resilient performance in Q4 and full year FY25 amidst a challenging chemical ecosystem marked by China's overcapacities and raw material softening. The company achieved 11% overall volume growth for FY25, with a notable 218 bps improvement in gross margins. Strategic projects like Dahej and Lote are progressing as planned, with the latter commencing commercial sales. The recent LOI with Hitachi Energy signals a significant pivot into a new, high-growth sector, reinforcing the company's commitment to specialty chemicals and diversification.

Highlights

  • Full year FY25 volume growth was 11% overall, with specialty chemicals growing 7% and essentials (acetyls) at 12.5%.

  • Full year FY25 EBITDA margin improved to 9.4% from 9% in FY24, driven by gross margin improvement of 218 bps.

  • Q4 FY25 volume growth was 1%, with gross margin at 34.6% (down from 35.6% in Q4 FY24) due to lower essential price realization.

  • Adjusted EBITDA for Q4 FY25 was INR 590 million, compared to INR 900 million in Q4 FY24 (which included a one-time profit claim of INR 10 crores).

  • PAT margin for FY25 stood at 3.8% (vs 4.22% in FY24) and for Q4 FY25 at 3.1% (vs 5.7% in Q4 FY24).

  • The Dahej 'Indra Dhanush' project received EC and factory license, remaining on track for commissioning in H2 FY26.

  • The Lote fluoro intermediate setup saw its first positive commercial sales in Q4 FY25, targeting 40-60% of peak revenues by FY26.

  • Signed an LOI with Hitachi Energy, entering a new segment of power transmission and generation.

Key financials

2 periods

Q4 FY25

  • Volume Growth
    1%
  • Gross Margin
    34.6%
  • Adjusted EBITDA
    590 Mn
  • PAT Margin
    3.1%

FY25

  • Volume Growth
    11%
  • Gross Margin Improvement
    218 bps
  • EBITDA Margin
    9.4%
  • PAT Margin
    3.8%

What they filed

Q1 FY27: revenue up 39.7%, net profit up 223.8% against the same quarter last year.

₹ Cr · quarterly
Line itemQ2 FY25Q3 FY25Q4 FY25Q1 FY26Q2 FY26Q3 FY26Q4 FY26Q1 FY27
Revenue771 786 710 693 700 −9%719 −9%735 +4%968 +40%
EBITDA75 75 59 31 37 −51%50 −33%54 −8%114 +268%
Net profit28 29 22 21 11 −61%25 −14%22 +0%68 +224%
How to read this

₹ crore, as filed. The percentage beside a figure is the change against the same quarter a year earlier — never the quarter before, which would make every seasonal business look like it collapses and booms each year.

Segment breakdown

  • Specialty Business (FY25)
    23% EBITDA Margin7% Volume Growth
  • Essentials Business (FY25)
    3% EBITDA Margin12.5% Volume Growth (Acetyls)

Guidance & targets

Capacity

  • Lote Fluoro Intermediate Peak Revenues Capacity · FY26 · Medium confidence 40-60%
    the ambition continues to be that into FY '26, we are around 40% to 60% of the peak revenues that we have laid out for ourselves.

    — Rajan Venkatesh, MD and CEO

  • Dahej Plant Commissioning Capacity · H2 FY26 · Medium confidence H2 FY26
    Towards the second half of this year is what we are looking at. The mechanical completion, chemical charging all happening at our Dahej facility, and we'll be more granular closer to that commissioning period.

    — Rajan Venkatesh, MD and CEO

  • Dahej Plant Ramp-up Capacity · FY27-FY28 · High confidence starting FY27 and FY28
    So, we are really looking at the ramp-up starting into FY '27 and '28.

    — Rajan Venkatesh, MD and CEO

  • Ketene and Diketene Derivative Space Capability Capacity · High confidence doubled
    We will also be doubling our capability of the ketene and diketene derivative space.

    — Rajan Venkatesh, MD and CEO

Revenue

  • Miteni Peak Potential Revenue · FY27 · High confidence INR 200+ crores
    we have depicted in our slides that by FY '27, we're able to reach the peak potential of maybe close to about INR200 plus/minus crores.

    — Rajan Venkatesh, MD and CEO

Profitability

  • Return on Capital Employed (ROCE) Profitability · by 2028 · High confidence 20%
    You mentioned in one of the slides that we have a road map to achieve 20% ROCE by the year 2028?

    — Aryan Jain (analyst) referencing company slides

Product Mix

  • Ethyl Acetate Contribution to Essentials Basket Product Mix · FY28 · High confidence 65%

    From 85% today

    if you look at FY '24, ethyl acetate as part of our essentials basket was contributing 85% to our essential's basket. And the ambition that we have is in that FY '28-time horizon to bring this down to almost 65%.

    — Rajan Venkatesh, MD and CEO

Capex

  • Total Capex Capex · High confidence INR 1,100 crores
    So, we have total capex, which is about INR 1,100 crores, and a large part of that is expected to happen in 1H FY '26.

    — Rohit Nagraj (analyst) referencing company statements

Debt

  • Peak Term Loan Debt · by FY27-FY28 · High confidence INR 300-350 crores
    So, Rohit, I look at around INR 300 and INR 350 crores of term loan maximum, which I will pay off by, say, FY '27-'28.

    — Mahadeo Karnik, CFO

  • Peak Debt-Equity Ratio Debt · High confidence 0.23-0.30
    So, debt equity at peak would be around 0.23 or 0.30. Not more than that.

    — Mahadeo Karnik, CFO

Volume

  • Volume Improvement Volume · High confidence 1.7x
    So, our volumes will improve by 1.7x versus where we closed out in FY '24.

    — Rajan Venkatesh, MD and CEO

Risks & concerns

  • Global chemical ecosystem overcapacities

    medium

    Overcapacities in China and pressure in Europe continue to impact the overall chemical ecosystem, though Laxmi views its position as neutral to positive.

    Management acknowledged

  • Raw material price softening

    medium

    Acetic acid prices declined 11% and ethanol 15% YoY in FY25, impacting realizations, especially in essentials and to some extent specialties.

    Management acknowledged

  • Weakness in agro segment demand

    medium

    The agro segment continues to show weakness, impacting a portion of the company's specialty portfolio.

    Management acknowledged

  • Subdued ethyl acetate spreads

    medium

    Ethyl acetate spreads are currently in the range of $140-$150 per metric ton, significantly lower than the historical average of $225, placing the essentials portfolio in the bottom quartile.

    Management acknowledged

  • Regulatory phase-out of a specialty product

    low

    One product in the specialty portfolio is undergoing a regulatory phase-out, which will have a minor impact in H1, but a substitute is lined up.

    Management acknowledged

  • Acetic anhydride margin pressure

    low

    Margins for acetic anhydride, a smaller part of the portfolio, are also under pressure due to downstream market conditions.

    Management acknowledged

Areas of evasion (1)

  • granular details on Hitachi Energy LOI (due to early stage)

Q&A highlights

2 direct
Details on Hitachi Energy LOI and commercialization timeline Partial
We have signed the LOI. And as we speak now, we are in the next phase of detailing the contracts. So, signing -- ticking that box and we want to pin down the moving parts. Thereafter, is where we will go to our Board and seek final approvals. And then thereafter, I am very excited to share far more details in the granularity that you sought. So please bear with us.

Analyst sought specific details on the new strategic partnership, but management deferred granular information until contracts are finalized and board approvals are secured, indicating early stages of the collaboration.

Asked by Rohit Nagraj

Rationale for additional capital investment in Ethyl Acetate given overcapacities and external pricing dependency Direct
So, our thesis has been always the same, that whatever we do to win in our essentials basket, we need to look at economies of scale. And what this investment does, it is providing us economies of scale. A 70 KT single-line technology, we would be the first plant in India providing that economies of scale.

Analyst questioned the strategy behind investing in a commodity segment, and management justified it by emphasizing economies of scale and cost leadership to gain market share, even in a cyclical environment.

Asked by Jigar Shah

Funding strategy for total capex of INR 1,100 crores and peak debt-equity ratio Direct
So, Rohit, I look at around INR 300 and INR 350 crores of term loan maximum, which I will pay off by, say, FY '27-'28. So, debt equity at peak would be around 0.23 or 0.30. Not more than that.

Analyst inquired about the financial leverage for significant capex, and management provided clear, specific targets for peak debt and debt-equity ratio, reassuring investors about financial prudence.

Asked by Rohit Nagraj

3 min read 7 chapters

Detailed narrative

Macro Environment and Industry Outlook

The global chemical ecosystem continues to face challenges, particularly from overcapacities in China and pressure in Europe. Laxmi Organic views its exposure to the U.S. market (less than 10% of sales) as neutral to positive. The company noted a general softening in raw material prices, with acetic acid declining by 11% and ethanol by 15% year-on-year in FY25, impacting realizations. While most end-user industries like pharma and packaging show stable demand, the agro segment remains weak.

Full Year FY25 Financial Performance

For the full year FY25, Laxmi Organic achieved an 11% volume growth overall, with specialty chemicals contributing 7% and essentials (acetyls) growing by 12.5%. Gross margins improved by 218 basis points, reflecting effective cost control. Full year EBITDA margin stood at 9.4% (up from 9% in FY24), while PAT margin was 3.8% (down from 4.22% in FY24). The company maintained financial discipline, keeping debt levels low despite ongoing capex, with term loans reducing from INR 90 crores to INR 42 crores.

Q4 FY25 Performance and Margin Dynamics

Q4 FY25 saw a 1% volume growth. Gross margin for the quarter was 34.6%, a decrease from 35.6% in Q4 FY24, primarily due to lower price realization in the essential business compared to an exceptionally high Q4 FY24. Adjusted EBITDA for Q4 FY25 was INR 590 million, compared to INR 900 million in Q4 FY24 (which included a one-time profit claim of INR 10 crores). PAT margin for the quarter was 3.1% versus 5.7% in the prior year.

Strategic Projects: Dahej and Lote Updates

The 'Indra Dhanush' project at Dahej has received its Environmental Clearance (EC) and factory license, remaining on track for commissioning in the second half of FY26, with ramp-up expected to start in FY27-FY28. The fluoro intermediate setup at Lote achieved its first positive commercial sales in Q4 FY25, with an ambition to reach 40-60% of its peak revenues by FY26. The company confirmed that all Miteni R&D capabilities have been absorbed into its global innovation center in Navi Mumbai, with no team remaining in Italy.

New Strategic Partnership with Hitachi Energy

Laxmi Organic has signed a Letter of Intent (LOI) with Hitachi Energy, marking an entry into the new and interesting segment of power transmission and generation. Management expressed excitement about this pivot, which leverages the company's fluorination platform. Further details regarding the arrangement, technology transfer, and commercialization timelines will be shared after contracts are finalized and board approvals are obtained.

Segment Performance and Product Mix Strategy

For FY25, the specialty business maintained a strong EBITDA margin of 23%, while the essential business recorded a 3% EBITDA margin. The company aims to maintain specialty EBITDA margins in the 20-25% range, independent of market cycles. In the essentials segment, the strategic focus is to diversify from ethyl acetate, targeting a reduction in its contribution to the essentials basket from 85% in FY24 to 65% by FY28, by introducing import-substitute products like n-propyl acetate and butyl acetate.

Financial Targets and Capex Outlook

Laxmi Organic aims to achieve a 20% Return on Capital Employed (ROCE) by 2028. The company plans a total capex of approximately INR 1,100 crores, with a significant portion expected in 1H FY26. Despite this investment, management projects a maximum term loan of INR 300-350 crores, leading to a peak debt-equity ratio of 0.23-0.30, which they expect to pay off by FY27-FY28, indicating a prudent financial approach.

This is an AI-generated summary of a publicly available earnings call transcript.
View original transcript

More Chemicals earnings calls